Raloxifene (Evista), a "designer estrogen" from Lilly
There's lots of interest in raloxifene (Evista), a "designer estrogen" from Lilly. It has been covered on TV, in the news, etc.
It's being tested to prevent osteoporosis in postmenopausal women...as an alternative to using estrogen.
Raloxifene is a "selective estrogen receptor modulator"...it has both estrogen agonist AND antagonist effects.